Publications
- Improvement of Anaemia in Patients with Primary Myelofibrosis by Low-Dose Thalidomide and Prednisone2016 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Role of ruxolitinib in the treatment of primary myelofibrosis2015 | Faculty of Medicine in Hradec Králové
- Impact of immunomodulatory drugs in treatment of primary myelofibrosis2015 | Faculty of Medicine in Hradec Králové
- Case 2-2012: a 57-year-old woman with post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for primary myelofibrosis2012 | Faculty of Medicine in Hradec Králové
- Report of University Hospital Hradec Králové to the clinical trial protocol No: GS-US-352-0101Publication without faculty affiliation
- De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors2024 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, Faculty of Medicine in Pilsen
- The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib2024 | First Faculty of Medicine
- Immune deregulation in myelodysplastic syndromes - the role of cytokines and soluble adhesion molecules. A pilot study2023 | Faculty of Medicine in Hradec Králové
- Treatment of polycythemia vera with ropeginterferon alfa‑2b in a young woman with a successful pregnancy – case report2023 | Faculty of Medicine in Hradec Králové
- Karotidynie (TIPIC syndrom) u pacientky s paroxysmální noční hemoglobinurií2022 | Faculty of Medicine in Hradec Králové
Loading network view...